Metyrapone as Additive Treatment in Major Depression
Condition(s):Major Depressive DisorderLast Updated:August 12, 2005Completed
Hide Studies Not Open or Pending
Condition(s):Major Depressive DisorderLast Updated:August 12, 2005Completed
Condition(s):Major Depressive DisorderLast Updated:March 5, 2024Completed
Condition(s):Major Depressive DisorderLast Updated:September 3, 2020Completed
Condition(s):Major Depressive DisorderLast Updated:June 25, 2020Unknown status
Condition(s):Depressive Disorder, Major; Major Depressive Disorder (MDD)Last Updated:June 4, 2012Completed
Condition(s):Major Depressive DisorderLast Updated:February 15, 2012Completed
Condition(s):Major DepressionLast Updated:December 15, 2011Completed
Condition(s):Major Depressive DisorderLast Updated:October 24, 2023Completed
Condition(s):Relapse Rate of a Major Depressive Episode; Safety of Olanzapine in Subjects With Major DepressionLast Updated:February 9, 2023Withdrawn
Condition(s):Major Depressive DisorderLast Updated:January 20, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.